Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor
Journal:
Current Drug Targets
Volume:
6
Page:
275-287
Author(s):
R. Bianco, G. Daniele, F. Ciardiello and G. Tortora
Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Journal:
Current Drug Targets
Volume:
6
Page:
301-323
Author(s):
M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese and F. Caponigro
Drugging Cell Cycle Kinases in Cancer Therapy
Journal:
Current Drug Targets
Volume:
6
Page:
325-335
Author(s):
S. Blagden and J. de Bono
Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris
Journal:
Letters in Drug Design & Discovery
Volume:
2
Page:
228-231
Author(s):
G. Giannelli, C. Foti, C. Divella, F. Marinosci, D. Bonamonte and S. Antonaci
Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
281-301
Author(s):
Wenfang Xu and Qianbin Li
Cancer Gene Therapy Utilizing Interleukin-13 Receptor α2 Chain
Journal:
Current Gene Therapy
Volume:
5
Page:
213-223
Author(s):
Koji Kawakami
Lipid Nucleoside Conjugates for the Treatment of Cancer
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1079-1089
Author(s):
Richard L. Alexander and Gregory L. Kucera
Apoptosis Following Photodynamic Tumor Therapy: Induction, Mechanisms and Detection
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1151-1165
Author(s):
Kristjan Plaetzer, Tobias Kiesslich, Christian Benno Oberdanner and Barbara Krammer
The Akt/PKB Family of Protein Kinases: A Review of Small Molecule Inhibitors and Progress Towards Target Validation
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
109-125
Author(s):
Stanley F. Barnett, Mark T. Bilodeau and Craig W. Lindsley
Progress in the Discovery of Polo-like Kinase Inhibitors
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
181-197
Author(s):
Campbell McInnes, Mokdad Mezna and Peter M. Fischer